secwatch.observer — SEC 8-K summary
======================================

Issuer:     BriaCell Therapeutics Corp. (BCTX)
CIK:        0001610820
Form:       8-K
Filed at:   2026-06-03T01:32:29+00:00
Accession:  0001493152-26-026953
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BriaCell closes $4.7M best-efforts equity offering; 1.45M shares at $3.25 each
------------------------------------------------------------------------------

- Gross proceeds ~$4.7M from sale of 1,449,300 common shares at $3.25/share in a best-efforts offering.
- Placement agent ThinkEquity receives 7.5% cash fee and 5-year warrants for 72,465 shares at $4.0625.
- Net proceeds to be used for working capital, general corporate purposes, and business advancement.
- Offering closed June 2, 2026; shares issued under effective shelf registration statement (Form S-3).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1610820/000149315226026953/0001493152-26-026953-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1610820/000149315226026953/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-026953

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer